<--- Back to Details
First PageDocument Content
Health / Nursing research / Lymphoma / RAC / National Institutes of Health / Cell culture / Epstein–Barr virus / Clinical trial / CD30 / Biology / Medicine / Biotechnology
Date: 2013-12-09 14:49:03
Health
Nursing research
Lymphoma
RAC
National Institutes of Health
Cell culture
Epstein–Barr virus
Clinical trial
CD30
Biology
Medicine
Biotechnology

RECOMBINANT DNA ADVISORY COMMITTEE Minutes of Meeting June 16-17, 2010 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service

Add to Reading List

Source URL: osp.od.nih.gov

Download Document from Source Website

File Size: 421,66 KB

Share Document on Facebook

Similar Documents

Breast Implant Associated Lymphoma  What To Tell Your Patients A special information evening to be presented by

Breast Implant Associated Lymphoma What To Tell Your Patients A special information evening to be presented by

DocID: 1vp5j - View Document

MDACC  LEUKEMIA AND LYMPHOMA Europe and the USA Linking Knowledge and Practice

MDACC LEUKEMIA AND LYMPHOMA Europe and the USA Linking Knowledge and Practice

DocID: 1vhjk - View Document

Assessment RunCD30 Material The slide to be stained for CD30 comprised: 1-2. Tonsil, 3. Anaplastic large cell lymphoma (ALCL), 4. Embryonal carcinoma,

Assessment RunCD30 Material The slide to be stained for CD30 comprised: 1-2. Tonsil, 3. Anaplastic large cell lymphoma (ALCL), 4. Embryonal carcinoma,

DocID: 1v5rE - View Document

Assessment RunCD23 Material The slide to be stained for CD23 comprised: 1-2. Tonsil, 3. Mantle cell lymphoma, 4-5. B-CLL.

Assessment RunCD23 Material The slide to be stained for CD23 comprised: 1-2. Tonsil, 3. Mantle cell lymphoma, 4-5. B-CLL.

DocID: 1v4zE - View Document

Case Study:  Challenge: How to profile Leukemia & Lymphoma Society

Case Study: Challenge: How to profile Leukemia & Lymphoma Society

DocID: 1uCBK - View Document